Cargando…

Plasminogen and fibrinogen plasma levels in coronary artery disease

Detalles Bibliográficos
Autores principales:	Kazmi, Rashid S., Lwaleed, Bashir A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460402/ https://www.ncbi.nlm.nih.gov/pubmed/23047269 http://dx.doi.org/10.5581/1516-8484.20120067

Ejemplares similares

Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Lima, Luciana Moreira, et al.
Publicado: (2012)

Impaired Fibrinolysis in Angiographically Documented Coronary Artery Disease
por: Fernandes, Adriano Basques, et al.
Publicado: (2015)

Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease
por: Peng, Yong, et al.
Publicado: (2016)

Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms
por: Gorska-Ciebiada, Malgorzata, et al.
Publicado: (2015)

Can Plasma Fibrinogen Levels Predict Bleeding After Coronary Artery Bypass Grafting?
por: Jalali, Alireza, et al.
Publicado: (2014)

Clonal hematopoiesis, multi-omics and coronary artery disease
por: Nakao, Tetsushi, et al.
Publicado: (2022)

Platelets from platelet-rich-plasma versus buffy-coat-derived platelets: what is the difference?
por: Gulliksson, Hans
Publicado: (2012)

Coronary artery calcification: does it predict obstructive coronary artery disease?
por: Dharampal, A. S., et al.
Publicado: (2013)

Plasma Fibrinogen Concentration in Occlusive Arterial Disease
por: Ingram, G. I. C.
Publicado: (1952)

Comments on the evaluation of lymphocyte levels in a random sample of 218 elderly individuals from São Paulo city
por: Blomberg, Bonnie B., et al.
Publicado: (2011)

Comment on “Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia”
por: de Souza Torres, Lidiane
Publicado: (2014)

Comments on: "Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia"
por: Driss, Adel
Publicado: (2013)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Sickle cell disease: from the beginning until it was recognized as a public health disease
por: Naoum, Paulo Cesar
Publicado: (2011)

Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
por: Simpson, David C
Publicado: (2013)

Sexuality and sickle cell disease
por: Figueiredo, Maria Stella
Publicado: (2013)

Is sickle cell disease the same everywhere?
por: Hankins, Jane
Publicado: (2012)

Oxidative stress in sickle cell disease
por: Queiroz, Raphael Ferreira, et al.
Publicado: (2013)

Kidd system antigens and kidney disease()
por: Barros, Melca Maria Oliveira
Publicado: (2017)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Secondary myeloid neoplasias: an emerging group of diseases
por: Hernández-Rivas, Jesús M
Publicado: (2011)

Comments on renal abnormalities of sickle cell disease
por: Abbud-Filho, Mario
Publicado: (2013)

Oral features of graft-versus-host disease
por: Regina Torres, Sandra
Publicado: (2014)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Stressed ends: telomere attrition in chronic diseases()
por: Fok, Wilson Chun, et al.
Publicado: (2017)

Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients
por: Nance, Sandra Taddie, et al.
Publicado: (2013)

Sickle cell disease: looking back but towards the future
por: Cançado, Rodolfo Delfini
Publicado: (2012)

The Langerhans cell histiocytosis: a disease in search of an identity
por: Rodriguez-Galindo, Carlos
Publicado: (2011)

Comment on sickle cell disease and left ventricular hypertrophy()
por: Verissimo, Monica Pinheiro de Almeida
Publicado: (2015)

Animal models of human nutritional diseases: a short overview
por: de Vasconcelos, Carlos Augusto Carvalho
Publicado: (2012)

Dynamics of sickle cell disease as one of the determinants of quality of life
por: Ivo, Maria Lúcia, et al.
Publicado: (2013)

The interpretation of rare or novel variants: damaging vs. disease-causing()
por: Gutierrez-Rodrigues, Fernanda, et al.
Publicado: (2018)

Male baldness; association with coronary artery disease?
por: van der Wall, E.E.
Publicado: (2015)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Comprehensive healthcare for individuals with sickle cell disease - a constant challenge
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão()
por: Viana, Marcos Borato
Publicado: (2015)

Comment on: “Oral health-related quality of life in children and teens with sickle cell disease”()
por: Correa, Maria Elvira Pizzigatti
Publicado: (2016)

Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease()
por: Piva, Elisa
Publicado: (2015)

Quality of life in sickle cell disease: assessments by the 36-item Short Form Health Survey Questionnaire and Beck Depression Inventory
por: Ivo, Maria Lucia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pn856kmisu1ddv7jn68c2u6he9